sanjay-about

Dr. SANJAY KUMAR BHADADA

MD,DM (Endocrinology),MNAMS ,FICP,FRCPI, FAMS

Professor & Head Department of Endocrinology,

Post graduate Institute of Medical education and Research (PGIMER), Chandigarh

About Us

Dr. Sanjay Kumar Bhadada (MD, DM (Endocrinology and Metabolism), FICP, FRCPI and MNAMS) is working as Professor & Head in the department of Endocrinology, PGIMER, Chandigarh, premier medical institute of country, known for its research and patient care worldwide . He is the founder and current secretary of Punjab and Chandigarh chapter of RSSDI. He is an Ex National Executive and current Secretary of Indian Society for Bone and Mineral Research (ISBMR). He is the regular speaker at annual conferences of RSSDI, Endocrine society of India (ESI) and ISBMR. He has more than 160 publications in high impact factor journals, speaks about his research aptitude. He has received prestigious awards like M N Sen Oration award by ICMR in 2013, PN Shah Oration award by Endocrine Society of India in 2010 & Prof. Survir Singh Visiting Professorship by Association of Physicians of India in 2011.

He also delivered Sanofi Aventis senior lecturership at APICON and recently nominated for prestigious Prof. Shuvir singh oration award. He has research collaboration with International institutes like Henry Ford Hospital, Detroit, USA & Antwerep University, Belzium and national institutes like IIT Ropar, CDRI Lucknow, AIIMS New Delhi, Panjab University & IMTECH, Chandigarh. He is the Section Editor of the ESI manual of Endocrinology. His major field of interests is diabetes in young and bone and diabetes. He is core team member of simultaneous pancreas and kidney transplant program at PGIMER, Chandigarh. He was the organizing secretary of one of the best organized ESICON (year 2014) at PGIMER, Chandigarh.

His work on primary hyperparathyroidism (PHPT) is recognized throughout country. He made the first online Indian PHPT registry program (www.indianphptregistry.com) to compile the data on PHPT throughout Indiato better understand the epidemiology, clinical and biochemical aspects in PHPT from India and has published many papers on the different clinical and biochemical complications associated with PHPT.

He is also actively involved ineducating type 1 diabetes children and providing complementary insulin and glucostrips to poor and underprivileged young individuals with diabetes through social support groupcalled ADITI (Association of Diabetes (young) in Tricity ). He is founder and current secretary of ADITI.

 

Specialization - Primary Hyperparathyroidism, Rare Metabolic Bone disorders, Diabetes in Young

Award
  • Outstanding Mentor Laureate Award from Endocrine Society, USA 2. 2024.
  • Dr. Radharaman Teacher's Oration by the Society for the Promotion of Education in Endocrinology. 
  • Maria Louisa bianchi award(ECTS) 2024
  • Outstanding Achievement Award by the World India Diabetes Foundation (WIDF).
  • Late Dr. B N Srivastava & Late Sarandulari Shrivastava award (RSSDI) for the year 2019.
  • ICMR award Drs. Kunti & Om Prakash Oration Award, 2019 , MN Sen Oration Award in 2016.
  • Prof. S.P.S Teotia Oration: Indian PHPT Registry awarded by ISBMR 2018.
  • Subash Mukherjee Oration award at ESICON, 2016.
  • Charity award, ISPAE 2020 ( Indian Society for Paediatrics and Adolescent Endocrinology).
  • Best poster Award in Manila, Philippines, (OSPFI), 2019.
  • Young Investigator Award for year 2005 from Indian Society of Bone and Mineral Research.
  • ISG-Systopic Award in 2009 from Indian Society of Gastroenterology for presenting paper on “Prevalence and Predictors of Abnormal Bone Metabolism in Adult Celiac Patients”
  • P N Shah Memorial Oration award at Endocrine society of India conference (ESICON) in year 2010 at CMC, Vellore.
  • SANOFI AVENTIS SENIOR Lectureship in diabetes at APICON, 2012, Kolkata.
  • AR Seth Award for the year 2012 for the second best oral presentation at ESICON 2012 kolkata.
  • Prof. Survir Singh Visiting Professorship by Association of Physicians India for year 2013
  • ICMR M N SEN Oration award for year 2012on his research work on “Primary hyperparathyroidism (PHPT) in India”.

Memberships

  • Life member of European Calcified Tissue Society (ECTS)
  • Life member of Association of physicians of India (API)
  • Life member of Endocrine Society of India (ESI)
  • Life member of Research Society for the Studies of Diabetes in India (RSSDI)
  • Life member of Indian Society Bone and Mineral Research (ISBMR)
  • Life member of Indian Menopausal Society
  • Life member of Indian Thyroid Society (ITS) (Registration No. 1138)
  • Indian Society for Pediatric and Adolescent Endocrinology (ISPAE).
  • Indian Medical Association (IMA)
  • Executive Secretary of Endocrine Society of India 2008-09
  • Joint Secretary of Endocrine Society of India 2010-13
  • Member of National Academy of Medical Sciences (MNAMS).
  • Fellow of Indian College of Physicians (FICP).
  • Founder governing council Member and Joint Secretory of World Non-communicable disease federation
Research Projects
  • To study gene expression for Vitamin D Receptor (VDR) and Calcium Sensing Receptor (CaSR) in patients with Primary Hyperparathyroidism (PHPT) and its correlation with clinical outcome (Funded by Indian Council of Medical Research (ICMR), India , Oct 2010 – Sept 2013)
  • Establishment of a database of sequence variations in parathyroid-specific genes and elucidation of their molecular mechanism in the pathogenesis of primary hyperparathyroidism to confirm clinical diagnosis. (feb 2022-feb 2025)..
  • Evaluation of Polycomb Repressive Complex 2 (PRC2) Target Genes As Potential Epigenetic Regulators Of Sporadic Primary Hyperparathyroidism (Feb2021-Feb 2024).
  •  Identification of Epigenetic biomarkers for detection and diagnosis of primary hyperparathyroidism (Aug 2018- July 2021)
  • Identification of differentially expressed proteins in parathyroid tumors and their clinical correlation with the disease (Funded by - Indian Council of Medical Research (ICMR), India , Oct 2012 – Sept 2015)
  • To study promoter methylation status of CDKN2A, CDKN2B and RASSF1A gene in primary hyperparathyroidism (Funded by – Intramural grant from PGIMER, April 2013 – March 2015)
  • Expression profiling of mitogen activated protein Kinase (MAPK) signaling pathway molecules in patients with sporadic primary hyperparathyroidism and correlation with disease indices (Funded by - Endocrine Society of India, April 2016 – March 2018)
  • Functional and genetic characterization of microRNAs involved in sporadic parathyroid adenomas (Funded by - Intramural research grant by PGIMER, April 2015 – March 2017)
  • To study the promoter methylation of transcriptional regulators of calcium sensing receptor (CASR) in sporadic parathyroid tumors (Funded by - Intramural research grant by PGIMER, April 2016 – March 2018)
Team Section

Dr Shweta Varshey
Ph.D Student (2009-2013)

 Transcriptional and Translational regulation of Vitamin D Receptor (VDR) and calcium sensing Receptor (CASR) in patients with sporadic primary hyperparathyroidism

Dr Ashutosh Arya
Ph.D Student (2013-2017)

 Proteomics and genomics study of sporadic parathyroid tumors

Dr Gurjeet Kaur
Ph.D Student (2014-2019)

 Identification and Characterization of MicroRNAs Involved in Sporadic Parathyroid Tumors

Dr. Priyanka Singh
Ph.D Student (2015-2020)

 To study the epigenetic modifications in transcriptional regulators of calcium sensing receptor in primary hyperparathyroidism
PUBLICATIONS - Journal Articles - Only on PHPT
  1. Rao SD, Bhan A, Athimulam S, Kumari P, Pal R, Bhadada SK, Qiu S, Cook BC. Atypical Parathyroid Adenomas: Potential Mechanisms to Reconcile Adenoma Size and Disease Phenotype. Frontiers in Endocrinology.;14:10 2023.
  2. Pal R, Jignesh SR, Sanyasi S, Lohani S, Dahiya D, Bhadada SK. Revisiting Captain Charles Martell: witnessing the true face of primary hyperparathyroidism even in the twenty-first century. Archives of Osteoporosis. 2022 Dec;17(1):148.
  3.  Pal R, Bhadada SK, Kumari P, Dahiya D, Sood A. PSAT167 Asian-Indians With Symptomatic Primary Hyperparathyroidism Have Lower Body Weight At Presentation And Tend To Gain Weight Post-Curative Parathyroidectomy. Journal of the Endocrine Society. 2022 Nov;6(Supplement_1):A199-200.
  4.  Kaur G, Bhadada SK, Santra M, Pal R, Sarma P, Sachdeva N, Dhiman V, Dahiya D, Saikia UN, Chakraborty A, Sood A. Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism. Journal of Bone and Mineral Research. 2022 Oct;37(10):1860-75.
  5. Das L, Bhadada SK, Kumari P. Improved Mortality Outcomes in Primary Hyperparathyroidism: Significant Benefit of the Dedicated Indian PHPT Registry. Indian Journal of Endocrinology and Metabolism. 2021 Nov;25(6):507.
  6.  Abuji K, Dahiya D, Sood A, Parmar M, Bhadada SK, Vijayvergiya R, Behera A. Impact of curative parathyroidectomy on left ventricular functions assessed with 2D ECHO and MUGA study. Turkish Journal of Surgery. 2021 Dec;37(4):336.
  7. Singh P, Bhadada SK, Arya AK, Saikia UN, Sachdeva N, Dahiya D, Kaur J, Brandi ML, Rao SD. Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis. J Clin Endocrinol Metab. 2021 Aug 28:dgab626. doi: 10.1210/clinem/dgab626. Epub ahead of print. PMID: 34453169.
  8. Singh P, Bhadada SK, Dahiya D, Saikia UN, Arya AK, Sachdeva N, Kaur J, Behera A, Brandi ML, Rao SD. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4084-e4096. doi:
    10.1210/clinem/dgab374. PMID: 34077544; PMCID: PMC8475237.
  9. Kumari P, Arya AK, Pal R, Sood A, Dahiya D, Mukherjee S, Rastogi A, Bhadada SK. Comparison Of Profile Of Primary Hyperparathyroidism With And Without Type 2 Diabetes Mellitus: Retrospective Analysis From The Indian PHPT Registry. Endocr Pract. 2021 Sep 30:S1530-891X(21)01243-X. doi: 10.1016/j.eprac.2021.09.012. Epub ahead of print. PMID: 34601115.
  10. Nalbo D, Dahiya D, Sood A, Bhadada SK, Behera A, Nahar U. Surgical outcome of radio-guided parathyroidectomy in primary hyperparathyroidism. International Surgery Journal. 2021 Jan 29;8(2):681-5.
  11.  Arya AK, Bhadada SK, Kumari P, Agrawal K, Mukhopadhyay S, Sarma D, Rao SD. Differences in primary hyperparathyroidism between pre-and postmenopausal women in India. Endocrine Practice. 2021 Jul 1;27(7):710-5.
  12.  Das L, Bhadada SK, Arvindbhai SM, Dahiya D, Behera A, Dutta P, Bhansali A, Sood A, Singh P, Prakash M, Kumari P, Rao SD. Baseline renal dysfunction determines mortality following parathyroidectomy in primary hyperparathyroidism: analysis of Indian PHPT registry. J Bone Miner Metab.
    2021 Aug 15. doi: 10.1007/s00774-021-01256-9. Epub ahead of print. PMID: 34392465
  13.  Mukherjee S, Arya AK, Bhadada SK, Saikia UN, Sood A, Dahiya D, Behera A. Parathyroid Carcinoma: An Experience from the Indian Primary Hyperparathyroidism Registry. Endocr Pract. 2021 Sep;27(9):881-885. doi: 10.1016/j.eprac.2021.01.014. Epub 2021 Jan 27. PMID: 33515758.
  14.  Krishnaraju VS, Saikia UN, Bhadada SK, Mittal BR, Sood A, Singh P, Dahiya D, Kumari P. Cystic Parathyroid Adenomas: An Enigmatic Entity and Role of Tc-99 m Sestamibi Scintigraphy. Endocr Pract. 2021 Jun;27(6):614-620. doi: 10.1016/j.eprac.2020.11.010. Epub 2020 Dec 13. PMID: 34120702.
  15.  Dahiya D, Abuji K, Kumari P, Gautam A, Bhadada S, Sood A, Nahar U, Tandup C, Behera A. Surgical outcome after focused
    parathyroidectomy: experience from a tertiary care center in North India. Pol Przegl Chir. 2021 May 15;93(5):1-5. doi: 10.5604/01.3001.0014.8864. PMID:
    34552024.
  16. Singh P, Bhadada SK, Dahiya D, Arya AK, Saikia UN, Sachdeva N, Kaur J, Brandi ML, Rao SD. Reduced calcium-sensing receptor (CaSR) expression is epigenetically deregulated in parathyroid adenomas. The Journal of Clinical Endocrinology & Metabolism. 2020 Sep;105(9):3015-24.
  17. Weight gain after curative parathyroidectomy predicts increase in bone mineral density in patients with symptomatic primary hyperparathyroidism. Pal R, Arya AK, Aggarwal A, Singh P, Dahiya D, Sood A, Singh T, Ram S, Bhansali A, Bhadada SK. Clin Endocrinol (Oxf). 2020 Apr 14. doi: 10.1111/cen.14195
  18. Primary Hyperparathyroidism Presenting as Posterior Reversible Encephalopathy Syndrome: A Report of Two Cases. Pal R, Dutta A, Agrawal K, Jain N, Dutta P, Bhansali A, Behera A, Bhadada SK. J Clin Res Pediatr Endocrinol. 2020 Mar 4. doi: 10.4274/jcrpe.galenos.2019.2019.0181
  19. Triple tracer positivity in metastatic lymph nodes from well-differentiated neuroendocrine tumor in MEN 1 syndrome. Kavanal AJ, Bhadada SK, Sood A, Kaur G, Parwaiz A, Gulati A, Dahiya D, Mittal BR.J Nucl Med Technol. 2020 Feb 28:jnmt.119.237339. doi: 10.2967/jnmt.119.237339
  20. Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors. Arya AK, Singh P, Saikia UN, Sachdeva N, Dahiya D, Behera A, Rao SD, Bhadada SK. J Endocrinol Invest. 2020 Feb;43(2):247-253.
  21. Persistence of 'non-dipping' pattern in blood pressure after curative parathyroidectomy in apparently normotensive patients with symptomatic primary hyperparathyroidism. Pal R, Mukherjee S, Bhadada SK, Bhansali A, Puravoor J, Behera A. Minerva Endocrinol. 2019 Nov 28. doi: 10.23736/S0391-1977.19.03104-3
  22. Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature. Dutta A, Pal R, Jain N, Dutta P, Rai A, Bhansali A, Behera A, Saikia UN, Vishwajeet V, Collier D, Boon H, Korbonits M, Bhadada SK. J Endocr Soc. 2019 Sep 16;3(12):2224-2235.
  23. Minimally invasive parathyroid carcinoma-A missing entity between parathyroid adenoma and carcinoma: Scintigraphic and histological features. Singh P, Vadi SK, Saikia UN, Sood A, Dahiya D, Arya AK, Behera A, Mukherjee S, Arvindkumar SM, Bhadada SK.Clin Endocrinol (Oxf). 2019 Dec;91(6):842-850
  24. Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity. Thanseer NTK, Parihar AS, Sood A, Bhadada SK, Dahiya D, Singh P, Mittal BR.World J Nucl Med. 2019 Apr-Jun;18(2):198-200
  25. Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice. Singh A, Mia MM, Cibi DM, Arya AK, Bhadada SK, Singh MK.J Biol Chem. 2019 May 24;294(21):8336-8347
  26. Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples. Arya AK, Bhadada SK, Singh P, Dahiya D, Kaur G, Sharma S, Saikia UN, Behera A, Rao SD, Bhasin M. J Endocrinol Invest. 2019 May;42(5):577-590
  27. Frequency & predictors of pancreatitis in symptomatic primary hyperparathyroidism. Arya AK, Bhadada SK, Mukherjee S, Singh P, Rana SS, Dahiya D, Sood A, Saikia UN, Prakash M, Bhasin DK, Behera A, Walia R, Bhansali A. Indian J Med Res. 2018 Dec;148(6):721-727
  28. PRIMARY HYPERPARATHYROIDISM IN THE YOUNG: COMPARISON WITH ADULT PRIMARY HYPERPARATHYROIDISM. Mukherjee S, Bhadada SK, Arya AK, Singh P, Sood A, Dahiya D, Ram S, Saikia UN, Behera A. Endocr Pract. 2018 Dec;24(12):1051-1056
  29. Primary hyperparathyroidism: insights from the Indian PHPT registry. Bhadada SK, Arya AK, Mukhopadhyay S, Khadgawat R, Sukumar S, Lodha S, Singh DN, Sathya A, Singh P, Bhansali A. J Bone Miner Metab. 2018 Mar;36(2):238-245
  30. Giant mediastinal parathyroid adenoma presenting as bilateral brown tumour of mandible: a rare presentation of primary hyperparathyroidism. Talukder S, Behera A, Bhadada SK, Mitra S. BMJ Case Rep. 2017 Oct 23;2017:bcr201722072.
  31. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism. Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, Kalathoorakathu RR, Singh P, Dahiya D, Saikia UN, Rao SD. Clin Nucl Med. 2017 Dec;42(12):e491-e497
  32. PREVALENCE AND PREDICTORS OF PRIMARY HYPERPARATHYROIDISM AMONG PATIENTS WITH UROLITHIASIS. Sharma S, Rastogi A, Bhadada SK, Singh P, Varshney S, Behera A, Bhansali A, Singh SK, Rao SD. Endocr Pract. 2017 Nov;23(11):1311-1315.
  33. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas. Arya AK, Bhadada SK, Singh P, Sachdeva N, Saikia UN, Dahiya D, Behera A, Bhansali A, Rao SD.Sci Rep. 2017 Jun 9;7(1):3123
  34. Sensitive Detection of a Small Parathyroid Adenoma Using Fluorocholine PET/CT: A Case Report. Padinhare-Keloth TNTK, Bhadada SK, Sood A, Kumar R, Behera A, Radotra BD, Mittal BR. Nucl Med Mol Imaging. 2017 Jun;51(2):186-189.
  35. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP. Osteoporos Int. 2017 Jan;28(1):1-19
  36. Effect of curative parathyroidectomy on insulin resistance. Putnam R, Dhibar DP, Varshney S, Behera A, Mittal BR, Bhansali A, Rao SD, Bhadada SK. Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):784-789.
  37. Giant Cell Lesions Associated with Primary Hyperparathyroidism. Rai S, Rattan V, Bhadada SK. J Maxillofac Oral Surg. 2015 Dec;14(4):930-4
  38. Giant Cell Lesions Associated with Primary Hyperparathyroidism. Rai S, Rattan V, Bhadada SK. J Maxillofac Oral Surg. 2015;14 (4):930-4.
  39. The resolution of anemia after curative parathyroidectomy is sustained even after a decade. Bhadada SK, Arya AK, Parthan G, Singh P. Indian J Endocrinol Metab. 2015 ;19 (5):691-2.
  40. Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR. Indian J Med Res. 2014 ;139(5):694-9
  41. Changes in parathyroid proteome in patients with primary hyperparathyroidism due to sporadic parathyroid adenomas. Varshney S, BhadadaSK, Arya AK, Sharma S, Behera A, Bhansali A, Rao SD. Clin Endocrinol (Oxf). 2014 Oct;81(4):614-20.
  42. Effect of gender, biochemical parameters & parathyroid surgery on gastrointestinal manifestations of symptomatic primary hyperparathyroidism. Shah VN, Bhadada SK, Bhansali A, Behera A, Bhattacharya A, Nahar U, Bhasin D, Vadera B. Indian J Med Res. 2014 Feb;139(2):279-84.
  43. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature. Shah VN, Shah CS, Bhadada SK, Rao DS. Clin Endocrinol (Oxf). 2014 ; 80(6):797-803.
  44. Pseudoarthrosis and fracture: interaction between severe vitamin D deficiency and primary hyperparathyroidism. Rastogi A, Bhadada SK, Bhansali A. Singapore Med J. 2013 Nov; 54(11):e224-7.
  45. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas. Varshney S, Bhadada SK, Sachdeva N, Arya AK, Saikia UN, Behera A, Rao SD. J Clin Endocrinol Metab. 2013 ;98(10):E1631-5.
  46. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians. Varshney S, Bhadada SK, Saikia UN, Sachdeva N, Behera A, Arya AK, Sharma S, Bhansali A, Mithal A, Rao SD. Eur J Endocrinol. 2013, 7;169(1):109-16.
  47. Unusual association of primary hyperparathyroidism, papillary thyroid carcinoma, and follicular adenoma in a young female. Sridhar S, Saikia UN, Bhadada SK, Bhansali A, Singh R, Behra A. Indian J Endocrinol Metab. 2013;17(2):355-6.
  48. Oro-mandibular manifestations of primary hyperparathyroidism. Rai S, Bhadada SK, Rattan V, Bhansali A, Rao DS, Shah V.Indian J Dent Res. 2012; 23(3):384-7.
  49. Chief cell and clear cell parathyroid adenoma do not influence clinical and biochemical expression of the sporadic primary hyperparathyroidism. Varshney S, Bhadada SK, Nahar U, Shah VN, Bhansali A, Behera A . Endocrine. 2013;43(2):440-3.
  50. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V.J Postgrad Med. 2012;58(2):107-11.
  51. Anemia and thrombocytopenia improves after curative parathyroidectomy in a patient of primary hyperparathyroidism (PHPT). Bhadada SK, Sridhar S, Ahluwalia J, Bhansali A, Malhotra P, Behera A, Mittal BR. J Clin Endocrinol Metab. 2012; 97(5):1420-2.
  52. Pulmonary function tests in patients with primary hyperparathyroidism. Bhadada SK, Agrawal A, Shah VN, Bhansali A, Behera A, Bhattacharya A, Nahar U. Indian J Endocrinol Metab. 2012;16(3):414-6.
  53. Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Bhadada SK, Bhansali A, Shah VN, Rao DS. Singapore Med J. 2011;52(12) :890-3
  54. Spectrum of single photon emission computed tomography/computed tomography findings in patients with parathyroid adenomas. Chakraborty D, Mittal BR, Harisankar CN, Bhattacharya A, Bhadada SK. Indian J Nucl Med. 2011;26(1):52-5.
  55. High prevalence of cholelithiasis in primary hyperparathyroidism: a retrospective analysis of 120 cases. Bhadada SK, Bhansali A, Shah VN, Behera A, Ravikiran M, Santosh R. Indian J Gastroenterol. 2011;30(2):100-1.
  56. A pilot study on hypothalamo-pituitary-adrenocortical axis in primary hyperparathyroidism. Rajput R, Bhansali A, Bhadada SK, Behera A, Mittal BR, Sialy R, Khandelwal N. Indian J Med Res. 2009;130(4):418-22.
  57. Characteristics of primary hyperparathyroidism in adolescents. Bhadada SK, Bhansali A, Dutta P, Behera A, Chanukya GV, Mittal BR. J Pediatr Endocrinol Metab. 2008;21(12):1147-53
  58. Worsening of bone disease after curative surgery in primary hyperparathyroidism. Bhansali A, Shanmugasundar G, Bhadada SK, Walia R, Ravikumar P BMJ Case Rep. 2009;.pii: bcr12.2008.1357.
  59. Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis. Bhadada SK, Udawat HP, Bhansali A, Rana SS, Sinha SK, Bhasin DK.J Gastroenterol Hepatol. 2008 Jun;23(6):959-64
  60. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy. Bhadada SK, Bhansali A, Ahluwalia J, Chanukya GV, Behera A, Dutta P. Clin Endocrinol (Oxf). 2009;70(4):527-32.
  61. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas. Bhadada SK, Cardenas M, Bhansali A, Mittal BR, Behera A, Chanukya GV, Nahar U, Rao DS. Clin Endocrinol (Oxf). 2008 ;69(3):382-5.
  62. Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery. Bhansali A, Masoodi SR, Bhadada SK, Mittal BR, Behra A, Singh P. Clin Endocrinol (Oxf). 2006;65(3):340-5.
Book Chapters
  • Sudhaker d. Rao, Sanjay Kr Bhadada and A. Michael Parfitt. Parathyroid Growth: Normal and Abnormal in book “The Parathyroids”, Third Edition, Editors John P. Bilezikian, Robert Marcus, Micheal A. Levine, Claudio Marcocci, Shonni J Silverbeg, John T. Potts Jr. Elsevier, 2014. p255-272
  • Sudhakar D Rao, Bhadada SK, Role of Vitamin D Nutrition in Metabolic Syndrome and Cardiovascular Risk Published by ICP monograph 2013.
  • Bhadada SK, D Sudhakar Rao. Osteoporosis: Nonpharmacological management of osteoporosis Published by nature publishing group; 2012,p39-48.
  • Bhadada SK, Mithal A. A Primary Hyperparathyroidism: An Indian Perspective (eds.) ESI Manual of Clinical Endocrinology. Published by Endocrine society of India; 2012,p503-510.
  • Bhadada SK, Bhansali A, Bhat RV. Clinical presentation of primary hyperparathyroidism. An Asian Perspective on Nutritional and Metabolic Bone and stone Disease. CBS publisher & Distributor, New Delhi;2008, p-480-487.
  • Bhat RV, Bhadada S. Familial hypocalciuric hypercalcimia. An Asian Perspective on Nutritional and Metabolic Bone and stone Disease. CBS publisher & Distributor, New Delhi,2008: p509-513.
  • Shriram M, Bhadada S. Phosphate Homeostasis. An Asian Perspective on Nutritional and Metabolic Bone and stone Disease. . CBS publisher & Distributor, New Delhi,2008.p133-139.
COLLABORATORS

        

NATIONAL

Dr. Ambrish Mithal, Chairperson & Head, Max Hospital Gurgaon 
Dr.Ritu Trivedi, Sr.  Scientist, CDRI Lucknow,

INTERNATIONAL

Dr Sudhaker D Rao, Henry Ford Hospital Detroit USA 
Dr. Wim Van Hul- Antwerp, Belgium 
Dr. maria Luisa Brandi, University of Florence, Italy

Managed By
Department of Endocrinology Postgraduate Institute of Medical Education & Research
Chandigarh, India - 160012
2024 © PHPT Dashboard

flogo